For these reasons, the use of compounds able of restoring the level of acetylcholine through inhibition of the AChE and BChE enzymes, eliminating ROS, and attenuating inflammatory pathways can be a multitarget strategy for the treatment and management of AD [11,17]. The gene discussed is BCHE; the disease is Alzheimer disease.